Wealth Enhancement Advisory Services, LLC Ironwood Pharmaceuticals Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 23,886 shares of IRWD stock, worth $16,003. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,886
Previous 13,235
80.48%
Holding current value
$16,003
Previous $58,000
39.66%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IRWD
# of Institutions
222Shares Held
166MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$15.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$11 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$10.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$9.18 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$6.66 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $103M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...